Benzinga | Jul 6, 2021 10:17AM EDT

Cleveland BioLabs Announces Call To Discuss Stockholder Meeting Vote Results, Proposed Merger

Cleveland BioLabs, Inc. (NASDAQ:CBLI), an innovative biopharmaceutical company developing novel approaches to activate the immune system, today announced that the Company and Cytocom Inc., a leading biopharmaceutical company developing next generation therapeutics that target immune restoration and homeostasis, will host an investor call and live webcast on Wednesday, July 7 at 8:30 a.m. ET.